Top 10 Startups & Unicorns companies in Multiple sklerose by Highest Patent Value in the United States in 2020 – Discovery

Free Trial

The Multiple sklerose top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Multiple sklerose Startups & Unicorns in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	STARTUP ImStem Biotechnology, Inc.	Connecticut, United States	Neuromyelitis optica,Health care,Biotechnology, ...[+2]	Avg patent value: 2.11 M
2	STARTUP Mitochon Pharmaceuticals, Inc.	Pennsylvania, United States	Medicine,G protein-coupled receptor,Muscarinic agonist, ...[+2]	Avg patent value: 1.78 M
3	STARTUP Bioscience Pharma Partners LLC	Arizona, United States	Pathology,Medical equipment,Health care, ...[+1]	Avg patent value: 1.07 M
4	STARTUP Cellix Bio Pvt Ltd.	New Jersey, United States	Health care,Drug,Medical research, ...[+2]	Avg patent value: 716,000
5	STARTUP Viking Scientific, Inc.	California, United States	Medicine,Drug,Extended Release Formulations, ...[+2]	Avg patent value: 590,000
6	STARTUP Nacuity Pharmaceuticals, Inc.	Texas, United States	Clinical trial,Retinitis pigmentosa,Health care, ...[+2]	Avg patent value: 170,000
7	STARTUP Yamo Pharmaceuticals LLC	New York, United States	Medicine,Autism spectrum disorder,Glutamate receptor, ...[+2]	Avg patent value: 90,000
8	STARTUP Alkahest, Inc.	California, United States	Alkahest,Health care,Plasma therapy, ...[+2]	Avg patent value: 56,333
9	STARTUP Asterias Biotherapeutics, Inc.	California, United States	Biology,Medicine,Pharmacy and Therapeutics, ...[+2]	Avg patent value: 37,000
10	STARTUP Aspen Neuroscience, Inc.	California, United States	Health care,Pharmacy and Therapeutics,Neuroscience, ...[+2]	Avg patent value: 16,000